The Cooper Companies, Inc.
COO
Peringkat dalam Saham
#1888
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Harga Saham
$58.93
Kapitalisasi Pasar
$11.21B
Perubahan (1 hari)
1.32%
Perubahan (1 tahun)
-21.42%
Negara
US
Perdagangan The Cooper Companies, Inc. (COO)
Kategori
Healthcare
Laba untuk The Cooper Companies, Inc. (COO)
Laba pada Jul 2026 TTM: $462.40M
Menurut laporan keuangan terbaru dari The Cooper Companies, Inc., laba saat ini perusahaan adalah $462.40M. Pada tahun 2024, perusahaan memperoleh laba sebesar $582.30M, peningkatan dibandingkan laba tahun 2023 sebesar $412.90M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk The Cooper Companies, Inc. dari 2000 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $462.40M | -18.38% |
| 2025 | $566.50M | -2.71% |
| 2024 | $582.30M | 41.03% |
| 2023 | $412.90M | -13.13% |
| 2022 | $475.30M | -3.30% |
| 2021 | $491.50M | 84.43% |
| 2020 | $266.50M | -44.18% |
| 2019 | $477.40M | 43.84% |
| 2018 | $331.90M | -15.76% |
| 2017 | $394.00M | 33.27% |
| 2016 | $295.63M | 37.19% |
| 2015 | $215.49M | -27.33% |
| 2014 | $296.53M | -5.04% |
| 2013 | $312.27M | 13.37% |
| 2012 | $275.45M | 42.90% |
| 2011 | $192.76M | 54.92% |
| 2010 | $124.43M | 8.36% |
| 2009 | $114.83M | 50.68% |
| 2008 | $76.21M | 11,240.33% |
| 2007 | $672.00K | -99.08% |
| 2006 | $73.34M | -32.38% |
| 2005 | $108.46M | -3.58% |
| 2004 | $112.49M | 24.32% |
| 2003 | $90.49M | 38.85% |
| 2002 | $65.17M | 25.02% |
| 2001 | $52.13M | 23.74% |
| 2000 | $42.13M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $3.81B | 723.05% |
US
|
|
| $4.11B | 788.59% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 243.86% |
US
|
|
| - | - |
CH
|
